Ceramides: Nutrient Signals that Drive Hepatosteatosis

• Main Author: Scott A. Summers
• Format: Article
• Language: English
• Published: The Korean Society of Lipid and Atherosclerosis 2020-01-01
• Series: Journal of Lipid and Atherosclerosis
• Subjects: ceramides; steatohepatitis; insulin resistance; non-alcoholic fatty liver disease; diabetes
• Online Access: https://doi.org/10.12997/jla.2020.9.1.50

Ceramides are minor components of the hepatic lipidome that have major effects on liver function. These products of lipid and protein metabolism accumulate when the energy needs of the hepatocyte have been met and its storage capacity is full, such that free fatty acids start to couple to the sphingoid backbone rather than the glycerol moiety that is the scaffold for glycerolipids (e.g., triglycerides) or the carnitine moiety that shunts them into mitochondria. As ceramides accrue, they initiate actions that protect cells from acute increases in detergent-like fatty acids; for example, they alter cellular substrate preference from glucose to lipids and they enhance triglyceride storage. When prolonged, these ceramide actions cause insulin resistance and hepatic steatosis, 2 of the underlying drivers of cardiometabolic diseases. Herein the author discusses the mechanisms linking ceramides to the development of insulin resistance, hepatosteatosis and resultant cardiometabolic disorders.